Moreover, whether autism-associated memory impairments can be rescued in adulthood through KCC2 manipulation, or whether any potential benefit of enhancing KCC2 function is limited to a critical period during development, is unknown; a lack of pharmacological KCC2 activators prevents this question from being addressed (Cardarelli et al., 2017). This evidence concerns the gene SLC12A5 and memory impairment.